Earnings Outlook For Kiniksa Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $-0.17. The company's stock price has increased by 22.62% over the last 52-week period. Last quarter, the company beat EPS by $0.15, resulting in a 3.7% increase in the share price the next day.
October 30, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Kiniksa Pharmaceuticals is expected to report an EPS of $-0.17 in its upcoming earnings report. The company's stock price has been on an upward trend, increasing by 22.62% over the last 52 weeks.
The upcoming earnings report is a significant event for Kiniksa Pharmaceuticals. Given the company's history of beating EPS estimates, there is potential for a positive impact on the stock price. However, the estimated EPS is negative, which could have a negative impact. Therefore, the short-term impact is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100